Published in Infect Immun on February 01, 1981
Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C. Infect Immun (1982) 2.43
The incidence of scarlet fever. J Hyg (Lond) (1983) 1.15
Staphylococcal enterotoxins in scarlet fever complicating chickenpox. Postgrad Med J (1991) 0.85
Recovery of Staphylococcus aureus from multiple body sites in menstruating women. J Clin Microbiol (1984) 0.75
Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet (1978) 10.25
A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics (1974) 9.97
A purified group A streptococcal pyrogenic exotoxin. Physiochemical and biological properties including the enhancement of susceptibility to endotoxin lethal shock. J Exp Med (1970) 3.76
Host-parasite factors in group A streptococcal infections. Pyrogenic and other effects of immunologic distinct exotoxins related to scarlet fever toxins. J Exp Med (1960) 3.35
Mucocutaneous lymph node syndrome in the United States. Am J Dis Child (1976) 2.52
Nonspecific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins. Infect Immun (1978) 2.35
Heterogeneity of group A streptococcal pyrogenic exotoxin type B. Infect Immun (1978) 2.26
Further studies of group A streptococcal factors with lethal and cardiotoxic properties. J Infect Dis (1955) 2.20
Purification and physicochemical and biological characterization of a staphylococcal pyrogenic exotoxin. Infect Immun (1979) 1.88
Production of pyrogenic exotoxin by groups of streptococci: association with group A. J Infect Dis (1979) 1.77
Suppression of antibody response by group A streptococcal pyrogenic exotoxin and characterization of the cells involved. Infect Immun (1978) 1.58
Nonspecific T-lymphocyte mitogenesis by pyrogenic exotoxins from group A streptococci and Staphylococcus aureus. Infect Immun (1979) 1.51
Reinterpretation of the Dick test: role of group A streptococcal pyrogenic exotoxin. Infect Immun (1979) 1.41
Staphylococcal scarlet fever. N Engl J Med (1962) 1.38
Activation of murine T-suppressor lymphocytes by group A streptococcal and staphylococcal pyurogenic exotoxins. Infect Immun (1980) 1.03
Scarlet fever and necrotizing fascitis caused by coagulase-positive hemolytic Staphylococcus aureus, phage type 85. Ann Intern Med (1973) 0.99
The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature (1983) 19.44
Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis (1981) 8.40
Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med (1989) 8.01
Exotoxins of Staphylococcus aureus. Clin Microbiol Rev (2000) 7.35
Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. Nature (1996) 7.11
Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci U S A (1991) 5.46
Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol (2001) 4.48
Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med (1987) 4.38
Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet (1993) 4.06
Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol (1990) 3.89
A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome. Proc Natl Acad Sci U S A (1990) 3.76
Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet (1992) 3.46
Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2003) 3.33
Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. J Infect Dis (1983) 3.00
Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (Scarlet fever toxin). J Infect Dis (1993) 2.84
Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production. Infect Immun (1989) 2.77
Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet (1986) 2.69
The nucleotide and partial amino acid sequence of toxic shock syndrome toxin-1. J Biol Chem (1986) 2.63
Purification and characterization of group A streptococcal pyrogenic exotoxin type C. Infect Immun (1977) 2.59
An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA (1997) 2.52
Nucleotide sequence of the streptococcal pyrogenic exotoxin type B gene and relationship between the toxin and the streptococcal proteinase precursor. J Bacteriol (1990) 2.50
Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C. Infect Immun (1982) 2.43
Nonspecific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins. Infect Immun (1978) 2.35
Identification of a novel two-component regulatory system that acts in global regulation of virulence factors of Staphylococcus aureus. J Bacteriol (2001) 2.33
Outbreak of group A streptococcus septicemia in children. Clinical, epidemiologic, and microbiological correlates. JAMA (1991) 2.27
Heterogeneity of group A streptococcal pyrogenic exotoxin type B. Infect Immun (1978) 2.26
Nucleotide sequence of the staphylococcal enterotoxin C1 gene and relatedness to other pyrogenic toxins. Mol Gen Genet (1987) 2.21
Group A streptococcal phage T12 carries the structural gene for pyrogenic exotoxin type A. Mol Gen Genet (1984) 2.19
Recurrent toxin-mediated perineal erythema. Arch Dermatol (1996) 2.09
Production of staphylococcal enterotoxin F and pyrogenic exotoxin C by Staphylococcus aureus isolates from toxic shock syndrome-associated sources. Infect Immun (1983) 2.08
Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis (1993) 2.07
Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. J Clin Microbiol (1991) 2.07
Crystal structure of the superantigen staphylococcal enterotoxin type A. EMBO J (1995) 1.99
Group A streptococcal pyrogenic exotoxin: pyrogenicity, alteration of blood-brain barrier, and separation of sites for pyrogenicity and enhancement of lethal endotoxin shock. Infect Immun (1978) 1.96
Purification and physicochemical and biological characterization of a staphylococcal pyrogenic exotoxin. Infect Immun (1979) 1.88
Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project. J Infect Dis (1995) 1.88
Biochemical and biological properties of Staphylococcal enterotoxin K. Infect Immun (2001) 1.80
Acute group G streptococcal myositis associated with streptococcal toxic shock syndrome: case report and review. Clin Infect Dis (1996) 1.80
Preparation of toxic shock syndrome toxin-1. Methods Enzymol (1988) 1.78
Clindamycin-induced suppression of toxic-shock syndrome--associated exotoxin production. J Infect Dis (1984) 1.78
Production of pyrogenic exotoxin by groups of streptococci: association with group A. J Infect Dis (1979) 1.77
Nonpurulent response to toxic shock syndrome toxin 1-producing Staphylococcus aureus. Relationship to toxin-stimulated production of tumor necrosis factor. J Immunol (1988) 1.77
Streptococcal pyrogenic exotoxin type A (scarlet fever toxin) is related to Staphylococcus aureus enterotoxin B. Mol Gen Genet (1986) 1.74
Toxin and enzyme characterization of Staphylococcus aureus isolates from patients with and without toxic shock syndrome. Ann Intern Med (1982) 1.73
Toxic shock syndrome. A newly recognized complication of influenza and influenzalike illness. JAMA (1987) 1.69
Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B. Immunity (1998) 1.68
Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes. J Exp Med (1991) 1.66
Toxic-shock-syndrome toxin 1-induced proliferation of lymphocytes: comparison of the mitogenic response of human, murine, and rabbit lymphocytes. J Infect Dis (1985) 1.65
Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp Med (1995) 1.65
Group A streptococcal peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis. Am J Med (1989) 1.57
Reporting of toxic shock syndrome Staphylococcus aureus in 1982 to 1990. J Infect Dis (1991) 1.57
Nucleotide sequence of streptococcal pyrogenic exotoxin type C. Infect Immun (1988) 1.56
Molecular characterization of a novel Staphylococcus aureus serine protease operon. Infect Immun (2001) 1.52
Nonspecific T-lymphocyte mitogenesis by pyrogenic exotoxins from group A streptococci and Staphylococcus aureus. Infect Immun (1979) 1.51
Glycerol monolaurate inhibits the production of beta-lactamase, toxic shock toxin-1, and other staphylococcal exoproteins by interfering with signal transduction. J Bacteriol (1994) 1.50
Bacteriophage involvement in group A streptococcal pyrogenic exotoxin A production. J Bacteriol (1986) 1.49
Oxygen and carbon dioxide regulation of toxic shock syndrome toxin 1 production by Staphylococcus aureus MN8. J Clin Microbiol (2000) 1.49
Alteration of immune function by staphylococcal pyrogenic exotoxin type C: possible role in toxic-shock syndrome. J Infect Dis (1983) 1.48
Streptococcus pyogenes pharyngitis: characterization of strains by multilocus enzyme genotype, M and T protein serotype, and pyrogenic exotoxin gene probing. J Clin Microbiol (1992) 1.47
Association of toxic shock syndrome toxin-secreting and exfoliative toxin-secreting Staphylococcus aureus with Kawasaki syndrome complicated by coronary artery disease. Pediatr Res (1997) 1.47
Staphylococcus aureus associated with toxic shock syndrome: phage typing and toxin capability testing. Ann Intern Med (1982) 1.45
Immunochemical assays for toxic shock syndrome toxin-1. Methods Enzymol (1988) 1.44
Quantification and toxicity of group A streptococcal pyrogenic exotoxins in an animal model of toxic shock syndrome-like illness. J Clin Microbiol (1989) 1.43
Structure of toxic shock syndrome toxin 1. Biochemistry (1993) 1.43
Fluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxins. Infect Immun (1991) 1.43
Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II. Immunity (2001) 1.42
Reinterpretation of the Dick test: role of group A streptococcal pyrogenic exotoxin. Infect Immun (1979) 1.41
Analysis of toxic shock syndrome isolates producing staphylococcal enterotoxins B and C1 with use of southern hybridization and immunologic assays. Rev Infect Dis (1989) 1.40
Bacteriophage association of streptococcal pyrogenic exotoxin type C. J Bacteriol (1989) 1.40
A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor beta chain and major histocompatibility complex class II. J Exp Med (1998) 1.39
Distinct T-cell receptor V beta gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein. Infect Immun (1992) 1.37
Nucleotide sequences and biologic properties of toxic shock syndrome toxin 1 from ovine- and bovine-associated Staphylococcus aureus. J Infect Dis (1992) 1.34
Toxic shock syndrome Staphylococcus aureus: effect of tampons on toxic shock syndrome toxin 1 production. Obstet Gynecol (1984) 1.33
Cloning and characterization of the gene, speC, for pyrogenic exotoxin type C from Streptococcus pyogenes. Mol Gen Genet (1988) 1.28
Molecular, serological, and clinical features of 16 consecutive cases of invasive streptococcal disease. Southeastern Minnesota Streptococcal Working Group. Clin Infect Dis (1998) 1.24
Invasive group B streptococcal disease in children beyond early infancy. Pediatr Infect Dis J (1995) 1.24
Localization of biologic functions of toxic shock syndrome toxin-1 by use of monoclonal antibodies and cyanogen bromide-generated toxin fragments. J Immunol (1986) 1.24
Evidence for the involvement of endotoxin in toxic shock syndrome. J Infect Dis (1987) 1.22
The structure of the superantigen exfoliative toxin A suggests a novel regulation as a serine protease. Biochemistry (1997) 1.21
Immunobiologic and biochemical properties of mutants of toxic shock syndrome toxin-1. J Immunol (1994) 1.20
Toxic shock syndrome toxin 1 is encoded by a variable genetic element. Rev Infect Dis (1989) 1.20
Conservation of the biologically active portions of staphylococcal enterotoxins C1 and C2. Infect Immun (1989) 1.20
Development of streptococcal pyrogenic exotoxin C vaccine toxoids that are protective in the rabbit model of toxic shock syndrome. J Immunol (2000) 1.20
Localization of biologically important regions on toxic shock syndrome toxin 1. Infect Immun (1996) 1.19
Cloning of the gene, speB, for streptococcal pyrogenic exotoxin type B in Escherichia coli. Infect Immun (1988) 1.18
Molecular population genetic evidence of horizontal spread of two alleles of the pyrogenic exotoxin C gene (speC) among pathogenic clones of Streptococcus pyogenes. Infect Immun (1992) 1.16
Superantigen binding to a T cell receptor beta chain of known three-dimensional structure. J Exp Med (1995) 1.16
Biological and immunological properties of the carboxyl terminus of staphylococcal enterotoxin C1. Infect Immun (1989) 1.14
Comparative analysis of lipopolysaccharide-induced tumor necrosis factor alpha activity in serum and lethality in mice and rabbits pretreated with the staphylococcal superantigen toxic shock syndrome toxin 1. Infect Immun (2001) 1.14
Transfer of group A streptococcal pyrogenic exotoxin production to nontoxigenic strains of lysogenic conversion. Infect Immun (1980) 1.14
Clinical and microbiological characteristics of severe group A streptococcus infections and streptococcal toxic shock syndrome. Clin Infect Dis (1995) 1.13
Expression of staphylococcal enterotoxin C1 in Escherichia coli. Infect Immun (1987) 1.13
Antibodies to a surface-exposed, N-terminal domain of aggregation substance are not protective in the rabbit model of Enterococcus faecalis infective endocarditis. Infect Immun (2001) 1.13
Molecular requirements for T cell activation by the staphylococcal toxic shock syndrome toxin-1. J Immunol (1990) 1.12
Association of exotoxin-producing group A streptococci and severe disease in children. Pediatr Infect Dis J (1991) 1.11
A recalcitrant, erythematous, desquamating disorder associated with toxin-producing staphylococci in patients with AIDS. J Infect Dis (1992) 1.10
Inhibition of ribonucleic acid synthesis by group A streptococcal pyrogenic exotoxin. Infect Immun (1980) 1.09
Toxoids of streptococcal pyrogenic exotoxin A are protective in rabbit models of streptococcal toxic shock syndrome. Infect Immun (2000) 1.08
Effects of staphylococcal toxic shock syndrome toxin 1 on aortic endothelial cells. J Infect Dis (1991) 1.06
The crystal structure of exfoliative toxin B: a superantigen with enzymatic activity. Biochemistry (1999) 1.06